Featured News Image News Features | Sep 2 2026 Wu Tsai Neurosciences Institute Building a framework for oversight of neural organoid and assembloid research A new report on a seminal 2025 meeting supported by Wu Tsai Neuro and the Dana Foundation lays the groundwork for a global effort to monitor research and offer ethical guidance to the fast-growing field Image Podcast episodes | Aug 27 2026 Wu Tsai Neurosciences Institute After Ozempic: the revolution in peptide science Jonathan Long tells us about 100,000 newly discovered peptides, gray-market risks, and the hunt for exercise in a pill Image Podcast episodes | Aug 13 2026 Wu Tsai Neurosciences Institute Transcranial magnetic stimulation and the future of psychiatry Corey Keller explains TMS and his efforts to better understand and harness this promising approach to psychiatric care Image News Features | Aug 10 2026 Frontiers for Young Minds How Does Your Brain Predict the Future When You Hear Speech? Faculty Scholar Laura Gwilliams and colleagues dive into language neuroscience for curious kids Displaying 1 - 4 news posts of 4 Filter Sort by Newest to oldest Oldest to newest News Type Wu Tsai Neuro News Knight Initiative news Director's messages Research news Researcher profiles News Features Awards and honors Podcast episodes Press coverage Publications Research Theme NeuroHealth NeuroDiscovery Image Podcast episodes | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter perception? (Part 2) This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain. Image Podcast episodes | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine. Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine. Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc
Image News Features | Sep 2 2026 Wu Tsai Neurosciences Institute Building a framework for oversight of neural organoid and assembloid research A new report on a seminal 2025 meeting supported by Wu Tsai Neuro and the Dana Foundation lays the groundwork for a global effort to monitor research and offer ethical guidance to the fast-growing field
Image Podcast episodes | Aug 27 2026 Wu Tsai Neurosciences Institute After Ozempic: the revolution in peptide science Jonathan Long tells us about 100,000 newly discovered peptides, gray-market risks, and the hunt for exercise in a pill
Image Podcast episodes | Aug 13 2026 Wu Tsai Neurosciences Institute Transcranial magnetic stimulation and the future of psychiatry Corey Keller explains TMS and his efforts to better understand and harness this promising approach to psychiatric care
Image News Features | Aug 10 2026 Frontiers for Young Minds How Does Your Brain Predict the Future When You Hear Speech? Faculty Scholar Laura Gwilliams and colleagues dive into language neuroscience for curious kids
Image Podcast episodes | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter perception? (Part 2) This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain.
Image Podcast episodes | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine.
Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc
